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In a new approach towards the development of a ‘dual-wavelength dual-mechanism’ type of photosensitizer for use
in photodynamic therapy (PDT), covalently linked bichromophoric systems comprising of porphyrin (P) and
anthraquinone (AnQ) subunits have been synthesized and fully characterized by FAB-MS, IR, UV–Visible and 1H
NMR methods. The porphyrin donor and the anthraquinone acceptor subunits of these mono- or bis-intercalating
hybrid molecules are interspersed with either cholate or polymethylene spacers. There exists minimal ground- and
singlet-state interaction between the porphyrin and anthraquinone subunits in the giant-sized, cholate-interspersed
P–AnQ systems as revealed by a comparison of their spectroscopic and electrochemical properties with those of
the corresponding individual reference compounds. On the other hand, quenching of fluorescence observed for the
P–AnQ systems endowed with polymethylene spacers has been interpreted in terms of a possible intramolecular
electron transfer between the singlet porphyrin and the anthraquinone acceptor. When excited into their porphyrin
absorption band maxima, each new P–AnQ system could generate singlet molecular oxygen in good-to-moderate
yield. Wavelength-dependent photonuclease activity of these new bis-intercalating species has been examined.
Treatment of tumors by photodynamic therapy (PDT) of can-
cer requires a photosensitizer which is a single, nontoxic, stable
compound of known chemical structure that can be retained
with a high degree of selectivity in malignant tumors.1 In addi-
tion, from the photochemical point of view, an ideal photo-
sensitizer should be able to absorb light in the tissue-transparent
region (≈600–800 nm) and photogenerate high yields of 1O2
and/or other cytotoxic species. Hematoporphyrin derivative
(HpD or Photofrin II) is currently being marketed as an anti-
cancer drug, and second-generation PDT agents based on por-
phyrin and related macrocycles are under development.1,2 Most
of the synthetic efforts towards the second-generation photo-
sensitizers have relied upon the appropriate modification of the
porphyrin system in such a way that the derived macrocycles
either absorb in the far-red spectral region and/or photogen-
erate high yields of 1O2.
2 Simultaneously, in a new approach to
the design of PDT agents, we and others have endeavored to
impart molecular (and cellular) recognition abilities to por-
phyrin sensitizers with a view to localizing the sensitizer in the
desired subcellular components of the tumor.3,4 Thus, we have
recently reported the synthesis and photonuclease activity of
several porphyrin–DNA intercalator and porphyrin–chemo-
therapeutic drug conjugates.3 More recently, design and syn-
thesis of a new ‘dual-wavelength dual-mechanism’ series of
porphyrin–anthraquinone (P–AnQ) hybrids and advantageous
utilization of the photoactivities of both the chromophores
present on these hybrids in accentuating the DNA photo-
cleavage has been reported by us.5 Herein, we demonstrate that
our new approach can be extended to the design of more elab-
orate, bis-intercalating, P–AnQ systems having an additional
cellular-level recognition element (viz: cholic acid 6) in their
‘tweezer-like’ architecture. As a first step towards evaluating
their efficacy in PDT, the photonuclease activity of these new
hybrid molecules has been examined.
Results and discussion
The scheme leading to the synthesis of the new bis-intercalators
is illustrated in Scheme 1. The 5,15-bis(4-hydroxyphenyl)-
porphyrin 1 7 was treated with 7-deoxycholic acid in the
presence of 1,3-dicyclohexylcarbodimide (DCC) and 4-
(dimethylamino)pyridine (DMAP) to obtain the key precursor
2. Porphyrin 2 was esterified with anthraquinone-2-carboxylic
acid (AnQ2-CO2H) employing the same classical DCC–DMAP
procedure to yield the cholate-interspersed mono- and bis-
intercalators 3 and 4. Reaction of 1 with 3-bromopropan-1-ol
in K2CO3–DMF furnished the corresponding porphyrin diols,
which upon further reaction with AnQ2-CO2H under the
standard ester-forming conditions gave 5. The steps involved in
the preparation of conjugates 2–5 are quite straightforward and
the desired compounds are readily obtained in pure form and
good yield.
The structural identity of hybrid molecules 2–5 was firmly
established on the basis of elemental analyses, 1H and 13C
NMR, IR, UV–Visible and FAB-MS data (see Experimental
section). The 1H NMR spectra of conjugates 3 and 4 exhibit
clearly discernible peaks due to the three constituent partners
(i.e. porphyrin, deoxycholic acid and anthraquinone) present in
these molecules. For example, in the symmetrical compound 4,
resonances due to the two outermost meso- and the two inner
imino protons on the porphyrin ring appear at the two ends
(δ 10.29 and 3.22) of the spectrum. In between, the pyrrole
protons resonate as two doublets, at δ 9.40 and 9.11 (J 4.5 Hz),
the ortho and meta aryl protons are located at δ 7.79 and 7.58
(both doublets, J 8.5 Hz), and the anthraquinone protons
appear as a singlet (δ 8.86, 2H) and a complex multiplet (δ 8.23–
8.42, 12H). The δ 5.08–0.83 region of the spectrum is character-
ized by the peaks due to the protons on the cholate spacer
moieties with the 3-H resonance appearing as a characteristic
broad signal at δ 5.08. In the UV–Visible spectra, each new
porphyrin conjugate investigated in this study shows one Soret
band and four Q-bands in the visible region. The band due to
the anthraquinone moiety is located at 253–258 nm for com-
pounds 3–5. Further analysis of the UV–Visible spectra sug-
gests that the AnQ part of these hybrids strongly absorbs
between 200–375 nm, a region in which the porphyrin part
shows minimum absorbance. Analogously, the porphyrin part
of each hybrid shows bands in the wavelength region (400–700
nm) where the AnQ part of the molecule does not absorb. Thus,
the two chromophores on these hybrid molecules are individu-
2178 J. Chem. Soc., Perkin Trans. 1, 1999,  2177–2181
Scheme 1 Reagents and conditions: (i) 7-deoxycholic acid, THF, DCC, DMAP, 20 h; (ii) anthraquinone-2-carboxylic acid, CH2Cl2, DCC, DMAP,
2 h; (iii) anthraquinone-2-carboxylic acid, CH2Cl2, DCC, DMAP, 3 h; (iv) Br(CH2)3OH, K2CO3–DMF, 36 h; (v) anthraquinone-2-carboxylic acid,
CH2Cl2, DCC–DMAP.
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ally addressable. Comparison of the UV–Visible data of 3–5
with the spectra of 1 and AnQ (or AnQ2-CO2H) further sug-
gests that the λmax and the log ε (ε = molar extinction
coefficient)-values of these porphyrin–intercalator conjugates
are in the same range as those of the reference compounds.
Similarly, the redox potential data of 3–5 were also found to be
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in the same range as those of 1 and AnQ (or AnQ2-CO2H).
While the one-electron oxidation and reduction of the porphy-
rin part of the conjugates was observed at (0.96 ± 0.02) and
(1.25 ± 0.02) V respectively, the anthraquinone part could be
reduced at (0.78 ± 0.02) V. Collectively, 1H NMR, UV–
Visible and redox potential data of these new P–AnQ systems
suggest that there exists no ground-state interaction between
the porphyrin and anthraquinone chromophores in these
hybrids, the cholate spacer being seen to be both photo- and
electro-inactive.
On the other hand, fluorescence due to the porphyrin moiety
in bis-intercalator 5 was found to be quenched (Φf 0.03) in
comparison with the unlinked porphyrin 2 (Φf 0.095) or meso-
5,10,15,20-tetra(4-tolyl)porphyrin (H2TTP, Φf 0.13), see Fig. 1.
We reason that this quenching is due to a photoinduced
electron-transfer (PET) reaction from the porphyrin singlet
state to the appended quinone, as is true for the covalently
linked, porphyrin–quinone systems reported earlier.8 Interest-
ingly, the fluorescence quantum yields of 3 and 4 (Φf 0.085)
were found to be close to that of their common precursor 2.
Probably, the distance between the donor (D; porphyrin) and
the acceptor (A; quinone) is too large in these D–A systems
owing to the rigid framework provided by the cholic acid
spacer. In contrast, the polymethylene spacers in 5 are expected
to provide sufficient flexibility such that the P–AnQ distance is
short enough to promote an electron-transfer quenching pro-
cess in this bichromophoric system. Finally, the singlet oxygen
(1O2) quantum yields of 1–5, as estimated from the standard
method involving the bleaching of 1,3-diphenylisobenzofuran
(DPBF) 3,5 in DMF, were found to range from 0.62 (1), 0.68 (2),
0.58 (3, 4) to 0.43 (5) (±15%), with 5 showing the least ability
for 1O2 generation, as expected.
The nuclease activity of the new-generation PDT agents 3–5
and the corresponding unlinked, reference compounds was
investigated using the supercoiled plasmid DNA pBR 322 in the
presence and absence of light. While no nicking was observed in
the absence of light, irradiation of DNA in the presence of 3–5
at either 550 nm (porphyrin absorption) or 350 nm (AnQ
absorption) caused nicking and generation of relaxed circular
DNA, Fig. 2. Similarly, the reference porphyrin 1 showed only
marginal nicking when irradiated at 550 nm (and also 350 nm)
but, AnQ2-CO2H was seen to efficiently photocleave the DNA
upon excitation by a 350 nm light source. In no case, however,
was linearization of DNA evident even upon prolonged irradi-
ation of the plasmid in the presence of any of the compounds
investigated in this study. Based on the data obtained during
our previous studies on similar porphyrin–intercalator conju-
gates 3,5 and also on the basis of reported literature on the
Fig. 1 Fluorescence spectra of equi-absorbing solutions (CH2Cl2; A at
λexc 550 nm is 0.19) of compounds 2–5.
photochemistry of anthraquinone-based intercalators in the
presence of DNA,9 it is surmised that while the porphyrin-
based DNA photocleavage (550 nm excitation) is mediated by
1O2, that based on the quinone (350 nm excitation) is due to the
reactions of quinone triplet/anion radical with the biomolecule.
In this regard, it is interesting to note that the quinone anion
radical can also be generated via a PET-based pathway upon
excitation of hybrid 5 at 550 nm.
The photonicking efficiency follows the order 4 > 5 > 3 when
these hybrids are irradiated at 350 nm under the identical
experimental conditions of concentration and light-dose. While
the superior photonicking ability of 4 with respect to 3 can be
understood in terms of the bis-intercalating ability of the
former hybrid, the relative inability of the bis-intercalator 5 to
photocleave DNA is surprising. Probably, the spacer cholic acid
moieties play an important role in the binding of these PDT
agents with DNA. This supposition is consistent with the better
DNA-nicking ability (λexc 550 nm) of the bis-cholate porphyrin
2 in comparison with the rest of the compounds investigated in
this study. Finally, complete conversion of form I to form II
DNA could be achieved with hybrids 3–5 under the conditions
of white light (λ > 350 nm) irradiation, as was the case with the
porphyrin–quinone diads reported by us earlier.5
In summary, the results described here suggest that our
P–AnQ based ‘dual-wavelength dual-mechanism’ hybrid mole-
cules provide new possibilities towards the design of potent
photonucleases for use in PDT.
Experimental
Materials and methods
The chemicals and solvents utilized in this study were purchased
from either Aldrich Chemical Co. (USA) or BDH (Mumbai,
India). The solvents utilized for spectroscopic and electro-
chemical experiments were further purified using standard pro-
cedures.10 The supercoiled pBR 322 DNA (Bangalore Genie,
India) was used as received. Agarose (molecular biology grade)
and ethidium bromide were purchased from Bio-Rad (USA).
meso-5,15-Bis(4-hydroxyphenyl)porphyrin 1 was synthesized
as per a reported method.7
Fig. 2 Light-induced nuclease activity of porphyrin–anthraquinone
hybrids. (a) λexc = 350 nm (0.5 mW cm2; 380 mJ); Lane 1: untreated
pBR 322, Lanes 2–6: pBR 322 1, 2, 3, 4 and 5 respectively. (b)
λexc = 550 nm (0.5 mW cm2; 380 mJ); Lane 1: untreated pBR 322,
Lanes 2–6: pBR 322 1, 2, 3, 4 and 5, respectively. In each case, the
proportion DNA/Drug = 1 :1 and the samples were incubated for 1 h
before being irradiated using a 150 W Xe-arc lamp/monochromator
assembly. Electrophoresis experiments were carried out as described in
ref. 5.
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Elemental analyses were performed on a Perkin-Elmer model
2400 analyzer. UV-Visible spectra were recorded with a JASCO
Model 7800 UV–Visible spectrophotometer. Concentration of
the samples used for these measurements ranged from about
2 × 106 M (porphyrin Soret and AnQ bands) to 5 × 105 M
(porphyrin Q-bands). Extinction coefficients are measured in
dm3 mol1 cm1. While the 1H NMR spectra were recorded
with a Bruker NR-200 AT-FT NMR spectrometer, 13C spectra
were recorded on a JEOL 300 MHz spectrometer at an oper-
ating frequency of 75 MHz. In both cases, CDCl3 and tetra-
methylsilane (TMS) were employed as the solvent and internal
standard, respectively. The FAB-mass spectra were recorded
with a JEOL SX 102/DA-6000 mass spectrometer/data system.
Cyclic voltammetric experiments (CH2Cl2 and 0.1 M tetrabutyl-
ammonium perchlorate, TBAP) were performed on a Princeton
Applied Research (PAR) 174A polarographic analyzer coupled
with a PAR 175 universal programmer and a PAR RE 0074 x–y
recorder, as detailed in our previous studies.11 Steady-state
fluorescence spectra were recorded using a JASCO Model 777
spectrofluorimeter. The emitted quanta were detected at right
angles to the incident beam. The utilized concentrations of
the fluorophores were such that the optical densities at the
excitation wavelength (540 nm) were always less than 0.2. The
fluorescence quantum yields (Φf, ±10%) were estimated by
integrating the areas under the fluorescence curves and by using
meso-5,10,15,20-tetraphenylporphyrin (H2TPP) (Φf 0.13 in
CH2Cl2 for excitation into the porphyrin band, 540 nm) as the
standard.12 Refractive-index corrections have been incorpor-
ated while reporting the fluorescence data in various solvents.13
For the singlet oxygen (1O2)-yield measurements, 2.5 ml of a
DMF (saturated with AR-grade molecular oxygen) solution
containing 1.0 × 106 M concentration of a given sensitizer and
0.5–1.0 × 104 M DPBF was placed in a 1 cm path-length
quartz cuvette and irradiated at 550 ± 10 nm (a PTI Model
A1010 150 W Xe arc lamp coupled with a PTI Model S/N 1366
monochromator with 10 nm band-pass). The solution was
stirred during the irradiation period. The depletion of DPBF
due to its reactions with 1O2 was monitored at 410 nm spectro-
photometrically. The total depletion of DPBF was restricted to
10–15% of its original concentration and an average of five or
six depletion-rate runs were used for quantum-yield measure-
ments.14
For the gel electrophoresis experiments, supercoiled pBR 322
DNA (100 µM in nucleotide phosphate; buffer B: 10 mmol Tris,
pH 8.0) was treated with a 100 µM solution (buffer B  2–3%
DMF) of the P–AnQ conjugates and the mixture was incubated
for 1 h in the dark. The samples were then analyzed by 0.8%
agarose gel electrophoresis (Tris–acetic acid–EDTA buffer, pH
8.0) at 40 V for 5 h. The gel was stained with 1 µg ml1 ethidium
bromide for 0.5 h, after which it was analyzed using the UVP
gel documentation system GDS 2000 and was also directly
photographed and developed as described previously.3,5 Irradi-
ation experiments were carried out by keeping the pre-
incubated (dark, 1 h) samples inside the sample chamber of a
JASCO Model FP-777 spectrofluorimeter (λ 350 ± 10 nm or
550 ± 10 nm).
Porphyrin–deoxycholic acid hybrid molecule 2
To a stirred mixture of 1 (30 mg, 0.06 mmol), 7-deoxycholic
acid (50 mg, 0.13 mmol) and DMAP (1 mg) in dry THF (15 ml)
was added a solution of DCC (30 mg, 0.15 mmol) in dry THF
(5 ml) dropwise under N2 at ambient temp. The reaction was
monitored by TLC and was terminated after 20 h. The reaction
mixture was filtered to remove the precipitated dicyclohexyl-
urea (DCU) and the filtrate was washed with water, dried
(anhydrous Na2SO4) and concentrated. Purification of the resi-
due on silica gel chromatography (ethyl acetate–hexane, 2 :1,
v/v) furnished 2 (62 mg) in 82% yield, λmax [CH2Cl2 (log ε)]/nm
406 (6.04), 503 (4.98), 536 (4.57), 576 (4.45), 630 (3.91); 1H
NMR (200 MHz; CDCl3) δ 3.16 (2H, br s), 0.79 (6H, s), 0.94
(6H, s), 1.17 (6H, d), 1.27–2.20 (m, H), 2.78 (2H, m), 3.58 (1H,
br s), 4.08 (1H, s), 7.55 (4H, d), 8.28 (4H, d), 9.11 (4H, d), 9.40
(4H, d), 10.31 (2H, s); E1/2 (CH2Cl2 0.1 M TBAP; V vs. SCE)
0.98, 1.26.
Porphyrin–deoxycholic acid–anthraquinone triad 3
DCC (5 mg, 0.02 mmol) in dry CH2Cl2 (1 ml) was added drop-
wise to a stirred mixture of 2 (25 mg, 0.02 mmol), anthra-
quinone-2-carboxylic acid (AnQ2-CO2H, 4 mg, 0.02 mmol)
and DMAP (1 mg) in dry CH2Cl2 (8 ml), under N2 at room
temp. The reaction was complete in 2 h (TLC). The reaction
mixture was filtered to remove the precipitated DCU and the
filtrate was washed with water, dried (anhydrous Na2SO4) and
concentrated. Purification of the residue by column chrom-
atography on silica gel (ethyl acetate–hexane, 1.5 :1, v/v) fur-
nished the desired product 3 (28 mg) as a purple amorphous
solid in 82% yield, mp 195–197 C (Found: C, 77.40; H, 6.91; N,
3.75. C95H102N4O11 requires C, 77.31; H, 6.97; N, 3.80%). FAB-
MS (m/z) 1477 [M  H]. Calc. for C95H102N4O11: M. 1476; νmax
(KBr pellet)/cm1 3447br, 2936, 2870, 1746, 1717, 1676, 1503,
1451, 1418, 1271, 1244, 1202, 1165, 793, 737, 708; λmax[CH2Cl2
(log ε)]/nm 258 (5.44), 406 (6.01), 502 (4.91), 536 (4.57), 575
(4.41), 630 (3.93); 1H NMR (200 MHz, CDCl3) δ 3.18 (2H, br
s), 0.80 (3H, s), 0.83 (3H, s), 0.89 (3H, s), 0.95 (3H, s), 1.02–2.18
(58H, m), 2.85 (2H, m), 3.64 (1H, br s), 4.10 (1H, br s), 5.08
(1H, br s), 7.58 (4H, m), 7.81 (4H, m), 8.34 (6H, m), 8.87 (1H,
br s), 9.12 (4H, d), 9.42 (4H, d), 10.32 (2H, s); 13C NMR (75
MHz, CDCl3) δ 12.8 (2C), 12.9, 17.4, 17.5, 23.2 (2C), 23.7, 26.0,
26.1, 26.6, 27.0, 27.1, 27.6, 27.7, 28.8, 28.9, 29.7, 30.5, 31.0,
31.5, 31.6, 31.9, 32.3, 33.7, 33.8, 34.1, 34.2, 34.9, 35.2, 36.1,
36.4, 42.0, 42.1, 46.6, 46.7, 47.4, 48.3, 71.8, 73.2, 73.3, 76.0,
105.4, 118.0, 120.2, 127.0, 127.2, 128.3, 131.0, 131.7, 133.0,
133.0, 133.1, 134.0, 134.1, 134.3, 135.6, 138.8, 145.2, 147.1,
150.8, 164.5, 172.9, 181.9, 182.2; E1/2 (CH2Cl2, 0.1 M TBAP; V
vs. SCE) 0.95, 0.77, 1.23.
Porphyrin–deoxycholic acid–anthraquinone triad 4
DCC (10 mg, 0.05 mmol) in dry CH2Cl2 (1 ml) was added
dropwise to a stirred mixture of 2 (25 mg, 0.02 mmol), AnQ2-
CO2H (12 mg, 0.05 mmol) and DMAP (1 mg) in dry CH2Cl2
(10 ml) under N2 at room temp. The reaction was complete in
3 h (TLC). Work-up and purification of the reaction mixture, as
described above for 3, furnished 4 (24 mg) as a purple amorph-
ous solid in 77% yield, mp 228–230 C (Found: C, 77.19; H,
6.34; N, 3.24. C110H108N4O14 requires C, 77.26; H, 6.37; N,
3.28%). FAB-MS (m/z) 1711 [M  H]. Calc. for C110H108-
N4O14: M 1710; νmax (KBr pellets)/cm
1 2932, 1755, 1721, 1678,
1593, 1271, 1202, 1167, 930, 793, 737, 706; λmax[CH2Cl2 (log ε)]/
nm 258 (5.72), 407 (6.21), 502 (4.92), 538 (4.51), 575 (4.41), 630
(3.90); 1H NMR (200 MHz; CDCl3) δ 3.22 (2H, br s), 0.83
(6H, s), 1.02 (6H, s), 1.20–2.18 (58H, m), 2.85 (2H, m), 4.13
(1H, s), 5.08 (1H, br s), 7.58 (4H, d), 7.79 (4H, m), 8.23–8.42
(12H, m), 8.86 (2H, br s), 9.11 (4H, d), 9.40 (4H, d), 10.29 (2H,
br s); 13C NMR (75 MHz; CDCl3) δ 12.8, 17.5, 23.1, 23.7, 26.0,
26.6, 26.9, 27.6, 28.8, 31.0, 31.5, 32.3, 33.8, 34.2, 34.9, 35.2,
36.0, 42.0, 46.6, 47.4, 48.4, 73.2, 76.0, 105.3, 118.0, 120.2, 127.0,
127.1, 128.2, 131.0, 131.7, 132.93, 132.95, 132.97, 133.9, 134.0,
134.1, 135.5, 135.6, 138.8, 145.1, 147.0, 150.7, 164.4, 172.9,
181.7, 182.0; E1/2 (CH2Cl2, 0.1 M TBAP; V vs. SCE): 0.98,
0.79, 1.23.
Porphyrin–polymethylene–anthraquinone triad 5
A mixture of porphyrin 1 (60 mg, 0.12 mmol) and 1-bromo-3-
hydroxypropane (67 mg, 0.48 mmol) in dry DMF (5 ml) con-
taining anhydrous K2CO3 was stirred at room temp. for 36 h,
after which the reaction mixture was poured into 20 ml water
and extracted thrice with CHCl3. The organic layer was washed
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with water, dried (anhydrous Na2SO4) and concentrated. The
resulting residue, after chromatographic purification (alumina;
CHCl3–CH3OH, 10 :1, v/v), furnished a pure sample of meso-
5,15-bis[4-(3-hydroxypropyl)phenyl]porphyrin (45 mg) as a
purple amorphous solid in 60% yield, mp >300 C (Found: C,
74.68; H, 5.57; N, 9.22. C38H34N4O4 requires C, 74.74; H, 5.61;
N, 9.17%). λmax (CH2Cl2)/nm 408, 505, 540, 576, 631; 
1H NMR
(200 MHz; CDCl3) δ 3.10 (2H, br s), 2.28 (4H, t), 3.94 (4H,
m), 4.45 (4H, t), 7.36 (4H, d), 8.16 (4H, d), 9.10 (4H, d), 9.45
(4H, d), 10.40 (2H, s).
DCC (10 mg, 0.05 mmol) in dry CH2Cl2 (1 ml) was added
dropwise to a stirred mixture of meso-5,15-bis[4-(3-hydroxy-
propyl)phenyl]porphyrin (12 mg, 0.02 mmol), AnQ2-CO2H (12
mg, 0.05 mmol) and DMAP (1 mg) in dry CH2Cl2 (10 ml) under
N2 at room temp. Work-up and purification of the reaction
mixture, as described above for 4, furnished 5 (15 mg) as a purple
solid in 70% yield, mp >300 C (Found: C, 75.60; H, 4.25; N,
5.22. C68H46N4O10 requires C, 75.69; H, 4.30; N, 5.19%). λmax
[CH2Cl2 (log ε)] 253 (5.93), 409 (6.13), 505 (4.75), 539 (4.57),
576 (4.32), 632 (3.97); 1H NMR (200 MHz; CDCl3) δ 3.09
(2H, br s), 2.56 (4H, t), 4.52 (4H, m), 4.85 (4H, t), 7.38 (4H, d),
7.82 (4H, d), 8.18–8.54 (12H, m), 9.09 (6H, m), 9.39 (4H, d),
10.29 (2H, br s); E1/2 (CH2Cl2, 0.1 M TBAP; V vs. SCE) 0.94,
0.80, 1.28.
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